Article Versions Notes

Riste M, Marshall JL, Satti I, Harris SA, Wilkie M, Lopez Ramon R, Wright D, Wittenberg RE, Vermaak S, Powell Doherty R, et al. Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults. Vaccines. 2021; 9(4):396. https://doi.org/10.3390/vaccines9040396

Riste, Michael, Julia L. Marshall, Iman Satti, Stephanie A. Harris, Morven Wilkie, Raquel Lopez Ramon, Danny Wright, Rachel E. Wittenberg, Samantha Vermaak, Rebecca Powell Doherty, and et al. 2021. "Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults" Vaccines 9, no. 4: 396. https://doi.org/10.3390/vaccines9040396

Riste, M., Marshall, J. L., Satti, I., Harris, S. A., Wilkie, M., Lopez Ramon, R., Wright, D., Wittenberg, R. E., Vermaak, S., Powell Doherty, R., Lawrie, A., Conlon, C. P., Cosgrove, C., Gleeson, F., Lipman, M., Moss, P., Perrin, F., Dedicoat, M., Bettinson, H., & McShane, H. (2021). Phase I Trial Evaluating the Safety and Immunogenicity of Candidate TB Vaccine MVA85A, Delivered by Aerosol to Healthy M.tb-Infected Adults. Vaccines, 9(4), 396. https://doi.org/10.3390/vaccines9040396